Analysis of Kyoto University Renal Cancer (KURC) xenograft tumor models, KURC1, KURC2, KURC3, treated with sunitinib, a small molecule inhibitor of receptor tyrosine kinases that is used to treat RC. Results provide insight into molecular mechanisms underlying acquired sunitinib resistance in RC.
- Organism:
- Homo sapiens
- Type:
- Expression profiling by array,
count,
2 agent, 3 disease state, 3 individual sets
- Platform:
- GPL6244
- Series:
- GSE66346
- 9 Samples
Download data: CEL